Ernexia Therapeutics Files 8-K on Corporate Matters
Ticker: ERNAW · Form: 8-K · Filed: Jun 2, 2025 · CIK: 748592
| Field | Detail |
|---|---|
| Company | Ernexa Therapeutics Inc. (ERNAW) |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
Ernexia Therapeutics filed an 8-K on June 2, 2025, detailing corporate changes and shareholder votes.
AI Summary
Ernexia Therapeutics Inc. filed an 8-K on June 2, 2025, reporting on amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company, formerly known as Eterna Therapeutics Inc. and Brooklyn ImmunoTherapeutics, Inc., is incorporated in Delaware and has its fiscal year end on December 31.
Why It Matters
This filing provides updates on significant corporate actions and governance for Ernexa Therapeutics, which could impact its operational structure and shareholder engagement.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain material adverse information.
Key Players & Entities
- Ernexia Therapeutics Inc. (company) — Registrant
- Eterna Therapeutics Inc. (company) — Former company name
- Brooklyn ImmunoTherapeutics, Inc. (company) — Former company name
- NTN BUZZTIME INC (company) — Former company name
- June 2, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Ernexa Therapeutics Inc.?
The primary purpose is to report on amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on June 2, 2025.
What are some of the former names of Ernexa Therapeutics Inc. mentioned in the filing?
The filing mentions former names including Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., and NTN BUZZTIME INC.
In which state is Ernexa Therapeutics Inc. incorporated?
Ernexia Therapeutics Inc. is incorporated in Delaware.
What is the fiscal year end for Ernexa Therapeutics Inc.?
The fiscal year end for Ernexa Therapeutics Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Ernexa Therapeutics Inc. (ERNAW).